Comprehensive molecular profiling of small cell lung cancer patients treated with chemo-immunotherapy or chemotherapy alone

被引：0
|
作者：
Urbini, M. [1 ]
Canale, M. [1 ]
Flospergher, M. [2 ]
Andrikou, K. [2 ]
Cravero, P. [2 ]
Pasini, L. [1 ]
Dubini, A. [3 ]
Panzacchi, R. [4 ]
Bennati, C. [5 ]
Rossi, G. [6 ]
Tassinari, D. [7 ]
Valli, M. [8 ]
Delmonte, A. [2 ]
Crino, L. [2 ]
Ulivi, P. [1 ]
机构：
[1] IRCCS Ist Romagnolo Studio Tumori IRST Dino Amado, Biosci Lab, Meldola, Italy
[2] IRCCS Ist Romagnolo Studio Tumori IRST Dino Amado, Dept Med Oncol, Meldola, Italy
[3] Osped Morgagni Pierantoni Forli, Pathol Dept, Forli, Italy
[4] Osped Gen Provinciale M Bufalini, Pathol Dept, Cesena, Italy
[5] Osped Santa Maria Croci, Med Oncol Dept, Ravenna, Italy
[6] Fdn Poliambu Ianza Ist Osped, Oncol, Brescia, Italy
[7] Osped Infermi, Dept Med Oncol, Rimini, Italy
[8] Osped Infermi Rimini, Pathol Dept, Rimini, Italy
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.09.1248
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2017P
引用
收藏
页码：S1072 / S1073
页数：2
相关论文
共 50 条
  • [1] Chemo-immunotherapy is Associated With Better Survival Than Chemotherapy Alone In Stage IV Non-small Cell Lung Cancer
    Patel, K. H.
    Alpert, N.
    Tuminello, S.
    Taioli, E.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S360 - S361
  • [2] The role of inflammatory biomarkers in advanced non-small cell lung cancer patients treated with chemo-immunotherapy
    Zattarin, E.
    Manglaviti, S.
    Galli, E.
    Apollonio, G.
    Beninato, T.
    Mazzeo, L.
    Massa, G.
    Bottiglieri, A.
    Ganzinelli, M.
    Proto, C.
    Ferrara, R.
    Prelaj, A.
    Galli, G.
    De Toma, A.
    Brambilla, M.
    Occhipinti, M.
    Garassino, M. C. C.
    De Braud, F. G. M.
    Lo Russo, G.
    ANNALS OF ONCOLOGY, 2021, 32 : S1010 - S1011
  • [3] CHEMOTHERAPY VERSUS CHEMO-IMMUNOTHERAPY FOR SMALL-CELL UNDIFFERENTIATED CARCINOMA OF THE LUNG
    AISNER, J
    WIERNIK, PH
    CANCER, 1980, 46 (12) : 2543 - 2549
  • [4] Immunotherapy alone or chemo-immunotherapy as front-line treatment for advanced non-small cell lung cancer
    Shafique, Michael
    Tanvetyanon, Tawee
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2019, 19 (03) : 225 - 232
  • [5] Metabolomics profiling in prediction of chemo-immunotherapy efficiency in advanced non-small cell lung cancer
    Mei, Lihong
    Zhang, Zhihua
    Li, Xushuo
    Yang, Ying
    Qi, Ruixue
    FRONTIERS IN ONCOLOGY, 2023, 12
  • [6] Real-world comparison of chemo-immunotherapy and chemotherapy alone in the treatment of extensive-stage small-cell lung cancer
    Lamy, Deborah
    Mouillot, Pierre
    Mariet, Anne-Sophie
    Barnestein, Robby
    Quilot, Fleur-Marie
    Fraisse, Clea
    Ghiringhelli, Francois
    Bonniaud, Philippe
    Zouak, Ayoube
    Foucher, Pascal
    RESPIRATORY MEDICINE AND RESEARCH, 2024, 86
  • [7] Chemo-immunotherapy A new option for non-small cell lung cancer
    Vitale, Giovanni
    Abbruzzese, Alberto
    Tonini, Giuseppe
    Santini, Daniele
    CANCER BIOLOGY & THERAPY, 2009, 8 (06) : 503 - 504
  • [8] Plasma lipidomics profiling in predicting the chemo-immunotherapy response in advanced non-small cell lung cancer
    Jiang, Hui
    Li, Xu-Shuo
    Yang, Ying
    Qi, Rui-Xue
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [9] The role of combination chemo-immunotherapy in advanced non-small cell lung cancer
    Rocco, Danilo
    Della Gravara, Luigi
    Battiloro, Ciro
    Gridelli, Cesare
    EXPERT REVIEW OF ANTICANCER THERAPY, 2019, 19 (07) : 561 - 568
  • [10] The Role of Neoadjuvant Chemo-Immunotherapy in Unresectable Non-Small Cell Lung Cancer
    Oh, M.
    Davis, A.
    Lentz, R.
    Peterman, N.
    Robertson, A.
    Srivas, R.
    Lambert, N.
    Wilson, T.
    Tezcan, H.
    Bharat, A.
    Chae, Y. K.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S947 - S948
12345